Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1974 Jul 20;111(2):147–149.

Screening programs for hypertension *

J Genest, O Kuchel, G Leduc, P Granger, R Boucher, J M Rojo-Ortega, W Nowaczynski
PMCID: PMC1947612  PMID: 4841837

Abstract

Major screening programs for hypertension are necessary for the following reasons: (a) the 12 to 15% prevalence of hypertension in the North American population; (b) the high proportion of hypertensive patients who are inadequately treated or whose disease is not even recognized; (c) the fact that in too many medical centres hypertension is poorly investigated or considered an insignificant finding; (d) the demonstration by many groups, especially the Framingham study, of hypertension as the major factor in the occurrence of severe cardiovascular disease; and (e) the achievement of a marked decrease in severe cardiovascular complications following adequate treatment. But such screening programs are of little value if unaccompanied by a major educational effort directed not only to the public but also to the medical profession, and a parallel increase in the funding of biomedical research into the basic physiopathological mechanisms of hypertension.

Full text

PDF
147

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Finnerty F. A., Jr Editorial: The hypertension problem. What we can do about it. Circulation. 1973 Oct;48(4):681–683. doi: 10.1161/01.cir.48.4.681. [DOI] [PubMed] [Google Scholar]
  2. Frohlich E. D., Emmott C., Hammarsten J. E., Linehan W. M., Pollack D., Horsley A. W. Evaluation of the initial care of hypertensive patients. JAMA. 1971 Nov 15;218(7):1036–1038. [PubMed] [Google Scholar]
  3. Kannel W. B., Castelli W. P., McNamara P. M., McKee P. A., Feinleib M. Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med. 1972 Oct 19;287(16):781–787. doi: 10.1056/NEJM197210192871601. [DOI] [PubMed] [Google Scholar]
  4. Kannel W. B., Gordon T., Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med. 1969 Jul;71(1):89–105. doi: 10.7326/0003-4819-71-1-89. [DOI] [PubMed] [Google Scholar]
  5. Kannel W. B., Gordon T., Schwartz M. J. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol. 1971 Apr;27(4):335–346. doi: 10.1016/0002-9149(71)90428-0. [DOI] [PubMed] [Google Scholar]
  6. Kannel W. B., Wolf P. A., Verter J., McNamara P. M. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA. 1970 Oct 12;214(2):301–310. [PubMed] [Google Scholar]
  7. Kuchel O., Leduc G., Genest J. Quelques concepts nouveaux dans la pathogénie et la thérapeutique de l'hypertension artérielle essentielle. Union Med Can. 1973 Apr;102(4):770–774. [PubMed] [Google Scholar]
  8. Mawar T., Rojo-Ortega J. M., Genest J. Eleven-year follow-up of a patient with malignant hypertension secondary to pyelonephritis and renal insufficiency. Can Med Assoc J. 1968 Jul 27;99(4):184–186. [PMC free article] [PubMed] [Google Scholar]
  9. McKee P. A., Castelli W. P., McNamara P. M., Kannel W. B. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971 Dec 23;285(26):1441–1446. doi: 10.1056/NEJM197112232852601. [DOI] [PubMed] [Google Scholar]
  10. Schoenberger J. A., Stamler J., Shekelle R. B., Shekelle S. Current status of hypertension control in an industrial population. JAMA. 1972 Oct 30;222(5):559–562. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES